
SSZ 500mg Tablet DR
Marketer
Cucard Pharma
Salt Composition
Sulfasalazine (500mg)
Overview SSZ 500mg Tablet DR
Sulfasalazine 500mg extended-release tablets treat diverse inflammatory conditions affecting the joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis and Crohn's disease). Ingestion should coincide with meals to minimize stomach upset. Consistent daily dosing, at the same time each day, maximizes therapeutic efficacy. Continue the prescribed regimen as directed by your physician, completing the full course even with symptom improvement. Ample water intake helps mitigate potential kidney complications, such as stone formation. Common side effects include nausea, headache, anorexia, vomiting, diarrhea, and gastrointestinal distress. Persistent or worsening side effects necessitate immediate consultation with your doctor, who can provide strategies for symptom management. Prior to commencing treatment, inform your doctor of any pre-existing heart, kidney, or liver conditions, and list all concurrent medications. Regular blood tests monitoring kidney and liver function, along with blood counts, may be recommended. Pregnant or breastfeeding individuals must seek medical advice before using this medication.
Uses of SSZ 500mg Tablet DR
Management of rheumatoid arthritis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and psoriatic arthritis.
Major Benefits of SSZ 500mg Tablet DR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 500mg SSZ extended-release tablet should be administered with a meal.
Common Side effects of SSZ 500mg Tablet DR:
- Diarrhea
- Gastrointestinal discomfort
- Headache
- Loss of appetite
- Nausea
- Oligospermia (low sperm count)
- Vomiting
How to use SSZ 500mg Tablet DR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The 500mg SSZ extended-release tablet should be administered with a meal.
How SSZ 500mg Tablet DR works:
Sulfasalazine 500mg extended-release tablets are classified as a disease-modifying antirheumatic drug (DMARD). Their mechanism of action involves dampening excessive immune responses in autoimmune disorders, thus inhibiting the inflammatory process by blocking inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking a 500mg sustained-release SSZ tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The 500mg extended-release SSZ tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of 500mg extended-release SSZ tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by the administration of 500mg delayed-release SSZ tablets.
KidneyCAUTION
The extended-release 500mg SSZ tablet requires careful administration for individuals with impaired kidney function. Dosage modification of the 500mg extended-release SSZ tablet might be necessary. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverUNSAFE
Patients with liver impairment should likely refrain from using SSZ 500mg Tablet DR, as it may pose safety risks. Medical advice is recommended.
What if you forget to take SSZ 500mg Tablet DR :
Should you forget to take a 500mg sustained-release SSZ tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About SSZ 500mg Tablet DR
| Label | Value |
|---|---|
| Chemical Type | Salicylate Analog |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Non-biologic Disease-Modifying Antirheumatic Drugs (DMARDs) |
